The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression

Background The role of the brain-derived neurotrophic factor (BDNF) in the pathogenesis of affective disorders such as depression has been controversial. Mounting evidence comes from structural imaging, that the functional BDNF Val66Met polymorphism influences the hippocampal volume with carriers of the 66Met allele (Val/Met and Met/Met group) having smaller hippocampi. Given that stress-induced atrophy of the hippocampus is associated with the pathogenesis of affective disorders, the functional BDNF Val66Met polymorphism could be an incremental risk factor. Method Eighty-seven healthy Caucasian participants underwent structural imaging and were genotyped for the BDNF Val66Met polymorphism. Data were analysed by means of voxel-based morphometry (VBM). Results Region of interest (ROI) analyses revealed an association between the 66Met allele and smaller parahippocampal volumes and a smaller right amygdala. In addition, the whole-brain analysis showed that the thalamus, fusiformus gyrus and several parts of the frontal gyrus were smaller in 66Met allele carriers. Conclusions This study demonstrates that the impact of the BDNF Val66Met polymorphism is not confined to the hippocampus but also extends to the parahippocampal gyrus and the amygdala.

[1]  C. Montag,et al.  The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans , 2010, Psychiatry Research.

[2]  B. Franke,et al.  Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity , 2010, Molecular Psychiatry.

[3]  M. Silhol,et al.  New insights into brain BDNF function in normal aging and Alzheimer disease , 2008, Brain Research Reviews.

[4]  Christian Montag,et al.  The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: Evidence from a genetic imaging study , 2008, NeuroImage.

[5]  Minjie Wu,et al.  Gray Matter Changes in Late Life Depression—a Structural MRI Analysis , 2008, Neuropsychopharmacology.

[6]  J. John Mann,et al.  Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  C. Montag,et al.  The BDNF Val66Met polymorphism and smoking , 2008, Neuroscience Letters.

[8]  J. P. Hamilton,et al.  Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies , 2008, Molecular Psychiatry.

[9]  Y. Kawasaki,et al.  Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons , 2008, Neuroscience Letters.

[10]  Hao-Jan Yang,et al.  The roles of personality traits and negative life events on the episodes of depressive symptoms in nonreferred adolescents: a 1-year follow-up study. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[11]  A. Meyer-Lindenberg,et al.  Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression , 2008, Molecular Psychiatry.

[12]  N. Burgess,et al.  The hippocampus and memory: insights from spatial processing , 2008, Nature Reviews Neuroscience.

[13]  M. Kudo,et al.  Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. , 2008, Molecular endocrinology.

[14]  H. Wittchen,et al.  Human and economic burden of generalized anxiety disorder , 2008, Depression and anxiety.

[15]  Karl J. Friston,et al.  Voxel-based morphometry , 2007 .

[16]  E. Walker,et al.  The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions , 2007, Brain Research.

[17]  Aron Halfin,et al.  Depression: the benefits of early and appropriate treatment. , 2007, The American journal of managed care.

[18]  K. Lesch,et al.  Long story short: the serotonin transporter in emotion regulation and social cognition , 2007, Nature Neuroscience.

[19]  H. Manji,et al.  New insights into BDNF function in depression and anxiety , 2007, Nature Neuroscience.

[20]  J. Groves,et al.  Is it time to reassess the BDNF hypothesis of depression? , 2007, Molecular Psychiatry.

[21]  E. Røysamb,et al.  Symptoms of Anxiety and Depression in Young Adults: Genetic and Environmental Influences on Stability and Change , 2007, Twin Research and Human Genetics.

[22]  Falk W. Lohoff,et al.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking , 2007, Psychopharmacology.

[23]  Norihiro Sadato,et al.  Volume of left amygdala subregion predicted temperamental trait of harm avoidance in female young subjects. A voxel-based morphometry study , 2006, Brain Research.

[24]  Nancy L Pedersen,et al.  The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample , 2006, Psychological Medicine.

[25]  C. Siao,et al.  Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.

[26]  T. Wassink,et al.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. , 2006, Archives of general psychiatry.

[27]  Michael Davis,et al.  Amygdala BDNF signaling is required for consolidation but not encoding of extinction , 2006, Nature Neuroscience.

[28]  Mark Slifstein,et al.  Effect of Spatial Smoothing on t-Maps: Arguments for Going Back from t-Maps to Masked Contrast Images , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Margit Burmeister,et al.  BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects , 2006, Biological Psychiatry.

[30]  H. Yamasue,et al.  Prefrontal Cortex and Amygdala Volume in First Minor or Major Depressive Episode After Cancer Diagnosis , 2006, Biological Psychiatry.

[31]  M. Alda,et al.  Prospective study of hippocampal volume and function in human subjects treated with corticosteroids , 2006, European Psychiatry.

[32]  Petti T. Pang,et al.  The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.

[33]  D Robinson,et al.  Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation , 2005, Molecular Psychiatry.

[34]  Dennis S. Charney,et al.  Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects , 2005, Biological Psychiatry.

[35]  Xueying Jiang,et al.  BDNF Variation and Mood Disorders: A Novel Functional Promoter Polymorphism and Val66Met are Associated with Anxiety but Have Opposing Effects , 2005, Neuropsychopharmacology.

[36]  J. Bremner,et al.  MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders , 2005, Molecular Psychiatry.

[37]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[38]  Michael Davis,et al.  Brain-Derived Neurotrophic Factor and Tyrosine Kinase Receptor B Involvement in Amygdala-Dependent Fear Conditioning , 2004, The Journal of Neuroscience.

[39]  Yogesh K. Dwivedi,et al.  Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. , 2003, Archives of general psychiatry.

[40]  H. Kraemer,et al.  Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.

[41]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[42]  Greg J Siegle,et al.  Relationships between Amygdala Volume and Activity during Emotional Information Processing Tasks in Depressed and Never‐Depressed Individuals , 2003, Annals of the New York Academy of Sciences.

[43]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[44]  H. Möller,et al.  Hippocampal changes in patients with a first episode of major depression. , 2002, The American journal of psychiatry.

[45]  J. Aubry,et al.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.

[46]  Richard J Davidson,et al.  Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms , 2001, Biological Psychiatry.

[47]  Robert M. Sapolsky,et al.  Depression, antidepressants, and the shrinking hippocampus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. R. Cloninger,et al.  A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.

[50]  C. Nemeroff,et al.  Hypercortisolemia and hippocampal changes in depression , 1993, Psychiatry Research.

[51]  C. Watts.  Psychiatry and Psychotherapy , 1966 .

[52]  T. Hajek,et al.  Hippocampal damage mediated by corticosteroids — a neuropsychiatric research challenge , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[53]  P. Sullivan,et al.  Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects , 2008, European Journal of Human Genetics.

[54]  M C Neale,et al.  A whole genome association study of neuroticism using DNA pooling , 2008, Molecular Psychiatry.

[55]  Osamu Abe,et al.  Gender-common and -specific neuroanatomical basis of human anxiety-related personality traits. , 2008, Cerebral cortex.

[56]  J. Gray,et al.  The neuropsychology of anxiety. , 1985, Issues in mental health nursing.

[57]  N. Martin,et al.  Genetic covariation between neuroticism and the symptoms of anxiety and depression , 1984, Genetic epidemiology.

[58]  K. Kolle.  [Psychiatry and psychotherapy]. , 1959, Deutsche Medizinische Wochenschrift.